Cardio-metabolic properties of manidipine: Beyond lowering arterial pressure?;Propiedades cardiometabólicas del manidipino: ¿más allá de la reducción de la presión arterial?

Nefrologia

Volumn 29, Issue 3, 2009, Pages 203-207

  Buset Rios N ^a   Rodriguez Esparragon F ^a   Rodriguez Perez J C ^a,b  

^a HOSPITAL UNIVERSITARIO DE GRAN CANARIA DR NEGRÍN   (Spain)

^b UNIVERSITY OF LAS PALMAS DE GRAN CANARIA   (Spain)

Author keywords

Calcium antagonists; Insulin resistance; Manidipine

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; DIHYDROPYRIDINE DERIVATIVE; MANIDIPINE;

BLOOD PRESSURE; DRUG EFFECT; HEART; HUMAN; METABOLISM; REVIEW;

BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; DIHYDROPYRIDINES; HEART; HUMANS;

EID: 70349246741     PISSN: 02116995     EISSN: None     Source Type: Journal    
DOI: 10.3265/NEFROLOGIA.2009.29.3.5078.EN.FULL     Document Type: Review

References (28)

1. Mathew B, Francis L, Kayalar A, Cone J. Obesity effects on cardiovascular disease and its diagnosis. J Am Board Fam Med 2008;21:562-8.
2. Yoshinaga M, Sameshima K, Tanaka Y, et al. Association between the number of cardiovascular risk factors and each risk factor level in elementary school children. Circ J 2008;72:1594-7.
3. Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003;42:1206-52.
4. Ueshiba H, Miyachi Y. Effects of the long-acting calcium channel blockers, amlodipine, manidipine and cilnidipine on steroid hormones and insulin resistance in hypertensive obese patients. Intern Med 2004;43:561-5.
5. Fogari R, Derosa G, Zoppi A et al. Effects of manidipine/delapril versus olmesartan/hydrochlorothiazide combination therapy in elderly hypertensive patients with type 2 diabetes mellitus. Hypertens Res 2008;31:43-50.
6. Wenzel RR. Renal protection in hypertensive patients: selection of antihypertensive therapy. Drugs 2005;65(2):29-39.
7. Abernethy DR, Schwartz JB. Calcium-antagonist drugs. N Engl J Med 1999;341:1447-57.
8. Gojanovic B, Feihl F, Liaudet L, Waeber B. Concomitant calcium entry blockade and inhibition of the renin-angiotensin system: a rational and effective means for treating hypertension. J Renin Angiotensin Aldosterone Syst 2008;9:1-9.
9. Hayashi K, Wakino S, Sugano N et al. Ca2+ channel subtypes and pharmacology in the kidney. Circ Res 2007;100:342-53.
10. Tiwari S, Zhang Y, Heller J, Abernethy DR, Soldatov NM. Atherosclerosisrelated molecular alteration of the human CaV1.2 calcium channel alpha1C subunit. Proc Natl Acad Sci USA 2006;103:17024-9.
11. Abernethy DR, Soldatov NM. Structure-functional diversity of human L-type Ca2+ channel: perspectives for new pharmacological targets. J Pharmacol Exp Ther 2002;300:724-8.
12. Bergh JJ, Shao Y, Puente E, Duncan RL, Farach-Carson MC. Osteoblast Ca(2+) permeability and voltage-sensitive Ca(2+) channel expression is temporally regulated by 1,25-dihydroxyvitamin D(3). Am J Physiol Cell Physiol 2006;290:C822-C831.
13. Hayashi K, Wakino S, Homma K, Sugano N, Saruta T. Pathophysiological significance of T-type Ca2+ channels: role of T-type Ca2+ channels in renal microcirculation. J Pharmacol Sci 2005;99:221-7.
14. Martínez Martín FJ. Calcium channel-blockers for managing metabolic syndrome-associated hypertension. Trials with manidipine. Nefrologia 2007;27(6):26-35.
15. Sabbatini M, Leonardi A, Testa R, Vitaioli L, Amenta F. Effect of calcium antagonists on glomerular arterioles in spontaneously hypertensive rats. Hypertension 2000;35:775-9.
16. Sharma AM, Janke J, Gorzelniak K, Engeli S, Luft FC. Angiotensin blockade prevents type 2 diabetes by formation of fat cells. Hypertension 2002;40:609-11.
17. Martínez Martín FJ. Manidipne (but not amlodipine), increases insulin sensitivity and rises plasma adiponectin cocentrations in hypertensive non-diabetic patients with metabolic syndrome and impaired fasting glucose. Diabetologia 2005;48(1):A374.
18. Fogari R, Derosa G, Zoppi A et al. Effect of delapril/manidipine vs olmesartan/ hydrochlorothiazide combination on insulin sensitivity and fibrinogen in obese hypertensive patients. Intern Med 2008;47:361-6.
19. Nakami T, Martínez MFJ. Manidipine prevents hepatic C-reactive protein production and reactive oxygen species generation by downregulation of the age receptor expression, dependent on PPARgamma activation. Journal of Hypertension 2007;25:S119-S120.
20. Oshimura H, Nakami T, Javier MF. Manidipine has a marked nonhaemodynamic nephroprotective action; Partly dependent on PPARgamma activation, and synergistic with angiotensin receptor blockade. Journal of Hypertension 2007;25:S8.
21. Meldolesi J. Inhibition of adipogenesis: a new job for the ER Ca2+ pool. J Cell Biol 2008;182:11-3.
22. Szabo E, Qiu Y, Baksh S, Michalak M, Opas M. Calreticulin inhibits commitment to adipocyte differentiation. J Cell Biol 2008;182:103-16.
23. Simon A, Levenson J. Effects of calcium channel blockers on atherosclerosis: new insights. Acta Cardiol 2002;57:249-55.
24. Adams DJ, Barakeh J, Laskey R, Van Breemen C. Ion channels and regulation of intracellular calcium in vascular endothelial cells. FASEB J 1989;3:2389-400.
25. Berkels R, Breitenbach T, Bartels H, et al. Different antioxidative potencies of dihydropyridine calcium channel modulators in various models. Vascul Pharmacol 2005;42:145-52.
26. Toba H, Nakagawa Y, Miki S, et al. Calcium channel blockades exhibit anti-inflammatory and antioxidative effects by augmentation of endothelial nitric oxide synthase and the inhibition of angiotensin converting enzyme in the N(G)-nitro-Larginine methyl ester-induced hypertensive rat aorta: vasoprotective effects beyond the blood pressure-lowering effects of amlodipine and manidipine. Hypertens Res 2005;28:689-700.
27. Toba H, Shimizu T, Miki S et al. Calcium [corrected] channel blockers reduce angiotensin II-induced superoxide generation and inhibit lectin-like oxidized low-density lipoprotein receptor-1 expression in endothelial cells. Hypertens Res 2006;29:105-16.
28. Sun X, Zemel MB. Calcitriol and calcium regulate cytokine production and adipocyte-macrophage cross-talk. J Nutr Biochem 2008;19:392-9.